title: Effects of weight loss in obese cats on biochemical analytes related to inflammation and glucose homeostasis.
abstract: The aim of the current study was to measure circulating metabolic and inflammation-related biochemical analytes in obese cats before and after weight loss. Thirty-seven overweight neutered cats were studied, median body weight 6.85 kg (range, 4.70 to 10.30 kg), representing a range of ages and both sexes. An individualized weight-loss program was devised for each cat and monitored until completion. Body fat mass was determined by dual-energy x-ray absorptiometry, whereas plasma concentrations of acute-phase proteins (APPs; eg, haptoglobin and serum amyloid A), hormones (eg, insulin, IGF-1, and adiponectin), and enzymes (eg, butyrylcholinesterase and paraoxonase type 1 [PON-1]) associated with inflammation and metabolic compounds (eg, glucose) were also measured. No significant changes were found in APPs after weight loss (P > 0.3), but significant increases in plasma adiponectin (P = 0.021) and IGF-1 (P = 0.036) were seen, whereas insulin (P < 0.001) and homeostasis model assessment (P = 0.005) decreased significantly. Plasma concentrations before weight loss of PON-1 (P = 0.004), adiponectin (P = 0.02), and IGF-1 (P = 0.048) were less in cats that failed to complete weight loss than cats that were successful, whereas glucose concentration was greater. Finally, multivariable linear regression analysis showed that lean tissue loss during weight management was associated with percentage weight loss (greater weight loss, greater lean tissue loss; R = 0.71, P < 0.001) and plasma adiponectin concentration before weight loss (lesser adiponectin, more lean tissue loss; R = -0.52, P = 0.023). In conclusion, various metabolic abnormalities occur in feline obesity, and these can be linked to outcomes of weight-loss programs. The changes that occur with weight loss suggest an improved metabolic status.
authors.affiliation: Department of Animal Medicine and Surgery, Veterinary School, University of Murcia, 30100 Murcia, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Tvarijonaviciute
authors.forename: J J
authors.initials: JJ
authors.lastname: Ceron
authors.forename: S L
authors.initials: SL
authors.lastname: Holden
authors.forename: P J
authors.initials: PJ
authors.lastname: Morris
authors.forename: V
authors.initials: V
authors.lastname: Biourge
authors.forename: A J
authors.initials: AJ
authors.lastname: German
mesh_terms: D052242:Adiponectin / Q000097:blood / Q000378:metabolism; D050154:Adiposity / Q000502:physiology; D000818:Animals; D043303:Aryldialkylphosphatase / Q000032:analysis / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis / Q000378:metabolism; D002091:Butyrylcholinesterase / Q000032:analysis / Q000378:metabolism; D002415:Cats; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006242:Haptoglobins / Q000032:analysis; D006706:Homeostasis / Q000502:physiology*; D007249:Inflammation / Q000378:metabolism*; D007328:Insulin / Q000097:blood / Q000378:metabolism; D007334:Insulin-Like Growth Factor I / Q000032:analysis / Q000378:metabolism; D008297:Male; D009765:Obesity / Q000097:blood / Q000378:metabolism*; D000685:Serum Amyloid A Protein / Q000032:analysis / Q000378:metabolism; D015431:Weight Loss / Q000502:physiology*
chemical_list: D052242:Adiponectin; D001786:Blood Glucose; D006242:Haptoglobins; D007328:Insulin; D000685:Serum Amyloid A Protein; D007334:Insulin-Like Growth Factor I; D002091:Butyrylcholinesterase; D043303:Aryldialkylphosphatase; D005947:Glucose